Priovant
Lisa McConnachie is Associate Director, Nonclinical Development at Priovant Therapeutics. She joins the Priovant team from Impel NeuroPharma, a small commercial-stage biotechnology company, where she spent two years leading the company's nonclinical programs for drug-device development, with an emphasis on nasal drug delivery. Prior to that role, Lisa spent 17 years with the University of Washington working as a Research Scientist in pharmacokinetics, drug metabolism, and toxicology, with an emphasis on translational sciences. Lisa holds a BS in Biology from Purdue University and an MS in Toxicology and a Ph.D. in Pharmaceutics (Drug Metabolism and Pharmacokinetics) from the University of Washington.
This person is not in any offices
Priovant
2 followers
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens.